JOHN JOHNSON
CIK 1410781 · Executive Chairman · last filed 2026-06-05
JOHN JOHNSON is an Executive Chairman who has filed 96 SEC Form 4 insider transactions across 13 companies since 2007. The most recent filing, for XERS, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$3.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.85M
13
96
-$3.23M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | Director | 683,083 | $6.79 | $4.64M | -$1.85M | 10 | 2026-06-05 |
| VSTM | Director | 52,666 | $4.10 | $215.9K | $0 | 10 | 2026-05-26 |
| AXGN | Director | 0 | $43.00 | $0 | -$1.91M | 10 | 2026-05-08 |
| Applied Therapeutics, Inc. (APLT) Delisted | Executive Chairman | 500,000 | $0.10 | $51.5K | $0 | 1 | 2024-12-20 |
| Strongbridge Biopharma plc (SBBP) Delisted | Chief Executive Officer | 0 | $2.00 | $0 | $0 | 11 | 2021-10-06 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 0 | — | — | $0 | 8 | 2020-07-02 |
| MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) Delisted | Chief Executive Officer | 37,400 | — | — | -$72.4K | 5 | 2019-07-02 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Director | 0 | — | — | $0 | 5 | 2018-02-13 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Director | — | $15.00 | — | $0 | 1 | 2018-02-05 |
| MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Director | 10,000 | — | — | $0 | 6 | 2017-01-05 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | Director | — | — | — | $0 | 2 | 2012-08-09 |
| SAVIENT PHARMACEUTICALS INC (SVNT) Delisted | Chief Executive Officer | 256,350 | — | — | $110.5K | 6 | 2012-01-04 |
| IMCLONE SYSTEMS INC (IMCL) Delisted | CEO | 0 | — | — | $500.0K | 4 | 2008-11-24 |
Recent Filings
96 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | XERS | Mixed | +9,193 | -$91.4K | EDGAR |
| 2026-05-26 | VSTM | Grant (A) | +36,000 | $0 | EDGAR |
| 2026-05-08 | AXGN | Mixed | — | -$400.2K | EDGAR |
| 2025-12-19 | XERS | Sell (S) | −135,400 | -$977.0K | EDGAR |
| 2025-12-10 | AXGN | Mixed | −24,943 | -$1.26M | EDGAR |
| 2025-08-15 | XERS | Sell (S) | −107,500 | -$786.5K | EDGAR |
| 2025-06-20 | AXGN | Grant (A) | — | $0 | EDGAR |
| 2025-06-11 | AXGN | Sell (S) | −4,073 | -$43.2K | EDGAR |
| 2025-06-04 | XERS | Grant (A) | +50,000 | $0 | EDGAR |
| 2025-05-27 | VSTM | Grant (A) | +8,333 | $0 | EDGAR |